Siolta Therapeutics develops therapies through understanding of human microbial ecology. The company combines clinical data, bioinformatics, and microbial science to develop combinations of bacteria that target disease-specific mechanisms of action.

Siolta Therapeutics

Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutics to improve outcomes in conditions with unmet medical needs. Our offices and laboratory are located in San Carlos, CA.  

National Institute of Allergy and Infectious Diseases

Seventure Partners

Global Brain Corporation

Khosla Ventures

SymBiosis LLC

Marc Benioff

Thanks @Ilana Golant @foodallergyfund – I’m excited to join an amazing group of folks elevating the conversation on food allergies! The Annual Food Allergy Fund Summit, held in New York City on May 23rd, will highlight the latest advancements and cutting-edge developments in food allergy research and innovation. 

Check out the agenda and support the cause here: https://lnkd.in/gs2tzeKu

Looking forward to supporting industry-academia cross-pollination at the Joint Berkeley Initiative for Microbiome Science (JBIMS) next week on May 9th from 2:00 PM to 6:00 PM at the Bakar BioEngenuity Hub at UC Berkeley.

This event aims to strengthen ties between leading microbiome researchers from academia and dynamic industry players. RSVP here: https://lnkd.in/gXH85Uxe 

Thanks to Eoin Brodie, Britt Koskella, and Matt Traxler for keeping us all connected!

Thanks to all of you supporting our vision of a better world where our healthcare, including drug development, is focused on solutions that alleviate disease from the start!

Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development

https://lnkd.in/gzStYAHg

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 25, 2024 7:12 AM	def78ad6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	cbdbf16e
crunchbase profile	general
li profile	general	Aug 25, 2024 7:12 AM	1f247024
translate crunchbase fundingrounds	general
peers	general	Aug 25, 2024 7:12 AM	5ea61688
news basic	general	Aug 25, 2024 7:12 AM	7b1ad448
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SIOLTATHERAPEUTICS

Siolta Therapeutics